CS241026B2 - Method of pyrazolo(1,5-c)-quinozoline derivatives production - Google Patents

Method of pyrazolo(1,5-c)-quinozoline derivatives production Download PDF

Info

Publication number
CS241026B2
CS241026B2 CS803407A CS340780A CS241026B2 CS 241026 B2 CS241026 B2 CS 241026B2 CS 803407 A CS803407 A CS 803407A CS 340780 A CS340780 A CS 340780A CS 241026 B2 CS241026 B2 CS 241026B2
Authority
CS
Czechoslovakia
Prior art keywords
group
alkyl
carbon atoms
hydrogen atom
formula
Prior art date
Application number
CS803407A
Other languages
Czech (cs)
English (en)
Other versions
CS340780A2 (en
Inventor
Edit Berenyi
Enikoe Szirt
Peter Goeroeg
Lujsa Petoecz
Ibolya Kosoczky
Agnes Kovacs
Gabriela Uermoes
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CS340780A2 publication Critical patent/CS340780A2/cs
Publication of CS241026B2 publication Critical patent/CS241026B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS803407A 1979-05-18 1980-05-16 Method of pyrazolo(1,5-c)-quinozoline derivatives production CS241026B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79EE2663A HU178523B (en) 1979-05-18 1979-05-18 Process for preparing new pyrazolo-quinazoline derivatives

Publications (2)

Publication Number Publication Date
CS340780A2 CS340780A2 (en) 1985-06-13
CS241026B2 true CS241026B2 (en) 1986-03-13

Family

ID=10995850

Family Applications (1)

Application Number Title Priority Date Filing Date
CS803407A CS241026B2 (en) 1979-05-18 1980-05-16 Method of pyrazolo(1,5-c)-quinozoline derivatives production

Country Status (17)

Country Link
US (1) US4303660A (ru)
JP (1) JPS55154974A (ru)
AT (1) AT375941B (ru)
AU (1) AU528013B2 (ru)
BE (1) BE883204A (ru)
CH (1) CH646170A5 (ru)
CS (1) CS241026B2 (ru)
DD (1) DD150897A5 (ru)
DE (1) DE3019019A1 (ru)
ES (1) ES8105319A1 (ru)
FR (1) FR2456744A1 (ru)
GB (1) GB2051054B (ru)
GR (1) GR68462B (ru)
HU (1) HU178523B (ru)
IT (1) IT1149882B (ru)
NL (1) NL8002853A (ru)
SU (3) SU978731A3 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469868A (en) * 1982-05-24 1984-09-04 Warner-Lambert Company Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines
DE3942357A1 (de) * 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh 3-aminopyrazolo-heterocyclen, deren verwendung zur bestimmung von wasserstoffperoxid, wasserstoffperoxid-bildenden systemen, peroxidase, peroxidatisch wirksamen substanzen oder von elektronenreichen aromatischen verbindungen, entsprechende bestimmungsverfahren und hierfuer geeignete mittel
EP1157026A1 (en) * 1999-02-22 2001-11-28 Boehringer Ingelheim Pharmaceuticals Inc. Polycyclo heterocyclic derivatives as antiinflammatory agents
GB2453116B (en) * 2007-09-25 2010-03-17 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methy1-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one in providing an analgesic effect
CN103130810B (zh) * 2013-03-11 2015-02-25 河南师范大学 一种吡唑并[1,5-c]喹唑啉类化合物的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313815A (en) * 1964-05-04 1967-04-11 Sterling Drug Inc 8-chloropyrazolo-[1, 5-c]quinazoline derivatives and methods of preparing same
US3531482A (en) * 1966-10-13 1970-09-29 Sandoz Ag Pyrazolo(1,5-c)quinazolines
US3897434A (en) * 1974-04-12 1975-07-29 Lilly Co Eli Pyrazolo{8 1,5-c{9 quinazolin-5(6H)-ones
US4076818A (en) * 1976-07-02 1978-02-28 E. R. Squibb & Sons, Inc. Pyrazolo [1,5-C]quinazoline derivatives and related compounds
US4112098A (en) * 1977-10-17 1978-09-05 E. R. Squibb & Sons, Inc. Pyrazolo[1,5-c]quinazoline derivatives and related compounds
US4110452A (en) * 1977-10-17 1978-08-29 E. R. Squibb & Sons, Inc. Pyrazolo (1,5-c) quinazoline derivatives and related compounds
US4198412A (en) * 1978-12-13 1980-04-15 E. R. Squibb & Sons, Inc. Pyrazolo [1,5-C] quinazoline derivatives and their use in treating allergic conditions

Also Published As

Publication number Publication date
JPH0227356B2 (ru) 1990-06-15
AU5848580A (en) 1980-11-20
DD150897A5 (de) 1981-09-23
GR68462B (ru) 1981-12-30
AU528013B2 (en) 1983-03-31
ATA262580A (de) 1984-02-15
ES491608A0 (es) 1981-05-16
SU1017171A3 (ru) 1983-05-07
NL8002853A (nl) 1980-11-20
JPS55154974A (en) 1980-12-02
IT8022111A0 (it) 1980-05-16
BE883204A (fr) 1980-11-10
US4303660A (en) 1981-12-01
GB2051054A (en) 1981-01-14
HU178523B (en) 1982-05-28
SU1015828A3 (ru) 1983-04-30
CH646170A5 (de) 1984-11-15
GB2051054B (en) 1983-05-18
DE3019019A1 (de) 1980-11-27
IT1149882B (it) 1986-12-10
FR2456744A1 (fr) 1980-12-12
ES8105319A1 (es) 1981-05-16
FR2456744B1 (ru) 1983-06-17
DE3019019C2 (ru) 1988-12-01
SU978731A3 (ru) 1982-11-30
AT375941B (de) 1984-09-25
CS340780A2 (en) 1985-06-13

Similar Documents

Publication Publication Date Title
KR870001201B1 (ko) 피롤로벤즈이미다졸 유도체의 제조방법
US4912107A (en) Pyrrolocarbazole derivatives, compositions containing them, and methods for using them
KR20040087335A (ko) 질소 함유 복소환 화합물
WO1992007830A2 (en) Oxindole peptide antagonists
EP0125607A2 (en) Pyrido(1,5)benzodiazepinone derivatives and pharmacological activities thereof
FI100530B (fi) Menetelmä substituoitujen diaminoftaali-imidien ja niiden analogien va lmistamiseksi
US3939161A (en) 1,3-Dimethyl- 1H-pyrazolo(4,3-D) pyrimidine-7 (6H)-ones
EP0491218A1 (en) Benzodiazepinones
JPH0369910B2 (ru)
US3962258A (en) 1,2,3,4,6,7,12,12B-Octahydro-2-benzamidoindolo[2,3-a]quinolizine
JPH0546348B2 (ru)
CA1082699A (en) Fused pyrimidine derivatives and process for the preparation thereof
WO1985004172A1 (en) Polyazaheterocyclic derivatives, process for their preparation, and pharmaceutical composition
CS241026B2 (en) Method of pyrazolo(1,5-c)-quinozoline derivatives production
JPH06763B2 (ja) ベンゾ〔ｈ〕シンノリン誘導体
IE55312B1 (en) Piperazine derivatives,their production and pharmaceutical compositions containing them
IE47249B1 (en) 4-aminoquinoline derivatives
JPH0441149B2 (ru)
US3647802A (en) 2-amino-4-aryl-3 4-dihydroquinolines
JP4385620B2 (ja) 含窒素複素環化合物
US3949081A (en) 4-Carbamoyl-1-benzazepines as antiinflammatory agents
JP2651912B2 (ja) イミダゾール誘導体、それらの製造法及び薬剤としての使用
US4677108A (en) 4-oxo-pyrido[2,3-d]pyrimidinone derivatives
JPH02212487A (ja) アヌレーション化インドール誘導体
US3859291A (en) 9-(p-anisidino)-7-methyl-(1h)-pyrazolo(3,4-f)quinoline